178 related articles for article (PubMed ID: 29750086)
1.
Zhang M; Liang Q; Zhang L; Hao Z; Zhou J; Zhang L; Fan S; Liang C
Dis Markers; 2018; 2018():1418609. PubMed ID: 29750086
[TBL] [Abstract][Full Text] [Related]
2. p27(Kip1) V109G polymorphism and cancer risk: a systematic review and meta-analysis.
Wei F; Xu J; Tang L; Shao J; Wang Y; Chen L; Guan X
Cancer Biother Radiopharm; 2012 Dec; 27(10):665-71. PubMed ID: 22823061
[TBL] [Abstract][Full Text] [Related]
3. CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.
Huang SP; Yu CC; Liu CC; Wu TT; Huang CH; Wu MT
Urol Int; 2008; 81(1):36-40. PubMed ID: 18645269
[TBL] [Abstract][Full Text] [Related]
4. hOGG1 rs1052133 Polymorphism and Prostate Cancer Risk: A Chinese Case-Control Study and Meta-Analysis.
Xu H; Zhang M; Hao Z; Liang C
Med Sci Monit; 2022 Oct; 28():e938012. PubMed ID: 36310366
[TBL] [Abstract][Full Text] [Related]
5. The V109G polymorphism in the p27 gene is associated with endometriosis.
Camargo-Kosugi CM; da Silva ID; Sato H; D'Amora P; Carvalho CV; Nogueira-de-Souza NC; Girão MJ; Schor E
Eur J Obstet Gynecol Reprod Biol; 2009 Aug; 145(2):180-3. PubMed ID: 19493606
[TBL] [Abstract][Full Text] [Related]
6. CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.
Zhang H; Li L; Xu Y
PLoS One; 2013; 8(7):e68634. PubMed ID: 23861929
[TBL] [Abstract][Full Text] [Related]
7. Genetic association between the cyclin-dependent kinase inhibitor gene p27/Kip1 polymorphism (rs34330) and cancer susceptibility: a meta-analysis.
Cheng XK; Wang XJ; Li XD; Ren XQ
Sci Rep; 2017 Mar; 7():44871. PubMed ID: 28317869
[TBL] [Abstract][Full Text] [Related]
8. Prognostic role of the CDNK1B V109G polymorphism in multiple endocrine neoplasia type 1.
Circelli L; Ramundo V; Marotta V; Sciammarella C; Marciello F; Del Prete M; Sabatino L; Pasquali D; Izzo F; Scala S; Colao A; Faggiano A; Colantuoni V;
J Cell Mol Med; 2015 Jul; 19(7):1735-41. PubMed ID: 25824098
[TBL] [Abstract][Full Text] [Related]
9. The protective effect of methylenetetrahydrofolate reductase C677T polymorphism against prostate cancer risk: Evidence from 23 case-control studies.
Guo S; Jiang X; Chen X; Chen L; Li X; Jia Y
Gene; 2015 Jul; 565(1):90-5. PubMed ID: 25841988
[TBL] [Abstract][Full Text] [Related]
10. Single-nucleotide polymorphism rs1058205 of KLK3 is associated with the risk of prostate cancer: A case-control study of Han Chinese men in Northeast China.
Chen C; Xin Z
Medicine (Baltimore); 2017 Mar; 96(10):e6280. PubMed ID: 28272245
[TBL] [Abstract][Full Text] [Related]
11. Association between the V109G polymorphism of the p27 gene and the risk and progression of oral squamous cell carcinoma.
Li G; Sturgis EM; Wang LE; Chamberlain RM; Spitz MR; El-Naggar AK; Hong WK; Wei Q
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):3996-4002. PubMed ID: 15217930
[TBL] [Abstract][Full Text] [Related]
12. Racial disparities in the association between diabetes mellitus-associated polymorphic locus rs4430796 of the HNF1β gene and prostate cancer: a systematic review and meta-analysis.
Xiang YZ; Jiang SB; Zhao J; Xiong H; Cui ZL; Li GB; Jin XB
Genet Mol Res; 2014 Aug; 13(3):6582-92. PubMed ID: 25177939
[TBL] [Abstract][Full Text] [Related]
13. The V109G polymorphism of the p27 gene CDKN1B indicates a worse outcome in node-negative breast cancer patients.
Schöndorf T; Eisele L; Göhring UJ; Valter MM; Warm M; Mallmann P; Becker M; Fechteler R; Weisshaar MP; Hoopmann M
Tumour Biol; 2004; 25(5-6):306-12. PubMed ID: 15627896
[TBL] [Abstract][Full Text] [Related]
14. Association between p21 Ser31Arg polymorphism and the development of cervical lesion in women infected with high risk HPV.
Lima G; Santos E; Angelo H; Oliveira M; Heráclio S; Leite F; de Melo C; Crovella S; Maia M; Souza P
Tumour Biol; 2016 Aug; 37(8):10935-41. PubMed ID: 26886286
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of p21 and p27 and pancreatic cancer risk in non-Hispanic Whites: a case-control study.
Chen J; Amos CI; Merriman KW; Wei Q; Sen S; Killary AM; Frazier ML
Pancreas; 2010 Jan; 39(1):1-4. PubMed ID: 19910837
[TBL] [Abstract][Full Text] [Related]
16. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
17. Association between the 8q24 rs6983267 T/G polymorphism and prostate cancer risk: a meta-analysis.
Zhu HS; Zhang JF; Zhou JD; Zhang MJ; Hu HX
Genet Mol Res; 2015 Dec; 14(4):19329-41. PubMed ID: 26782586
[TBL] [Abstract][Full Text] [Related]
18. p27 variant and corticotropinoma susceptibility: a genetic and in vitro study.
Sekiya T; Bronstein MD; Benfini K; Longuini VC; Jallad RS; Machado MC; Goncalves TD; Osaki LH; Higashi L; Viana J; Kater C; Lee M; Molatore S; Francisco G; Chammas R; Naslavsky MS; Schlesinger D; Gama P; Duarte YA; Lebrão ML; Zatz M; Meirelles O; Liberman B; Fragoso MC; Toledo SP; Pellegata NS; Toledo RA
Endocr Relat Cancer; 2014 Jun; 21(3):395-404. PubMed ID: 24532476
[TBL] [Abstract][Full Text] [Related]
19. Association of six susceptibility Loci with prostate cancer in northern chinese men.
Zhang YR; Xu Y; Yang K; Liu M; Wei D; Zhang YG; Shi XH; Wang JY; Yang F; Wang X; Liang SY; Zhao CX; Wang F; Chen X; Sun L; Zhu XQ; Zhu L; Yang YG; Tang L; Jiao HY; Huo ZH; Yang Z
Asian Pac J Cancer Prev; 2012; 13(12):6273-6. PubMed ID: 23464444
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.
Ma Q; Qi C; Tie C; Guo Z
Gene; 2013 Nov; 530(2):309-14. PubMed ID: 23973729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]